Yahoo
Johannesburg - Delayed Quote ZAc

Dis-Chem Pharmacies Limited (DCP.JO)

2,442.00 -353.00 (-12.63%)
At close: October 30 at 5:05:55 PM GMT+2
DCP.JO H1 2027 earnings call
Replay the call for the latest insights.
Chart Range Bar
Loading chart for DCP.JO
  • Previous Close 2,795.00
  • Open 2,725.00
  • Bid 2,464.00 x --
  • Ask 2,599.00 x --
  • Day's Range 2,442.00 - 2,725.00
  • 52 Week Range 2,442.00 - 3,885.00
  • Volume 3,332,154
  • Avg. Volume 1,340,207
  • Market Cap (intraday) 20.906B
  • Beta (5Y Monthly) 0.29
  • PE Ratio (TTM) 23.48
  • EPS (TTM) 1.04
  • Earnings Date Oct 29, 2026
  • Forward Dividend & Yield 0.51 (2.10%)
  • Ex-Dividend Date Nov 18, 2026
  • 1y Target Est 3,607.14

Dis-Chem Pharmacies Limited, together with its subsidiaries, engages in the retail and wholesale of healthcare products and pharmaceuticals in South Africa. The company operates through two segments: Retail and Wholesale. It owns and operates a chain of retail stores that offers various products, including dispensaries, personal care and beauty, healthcare and nutrition, baby care, and other products. The company also provides pharmaceutical, health, and front shop products in the wholesale market, health insurance products, occupational health clinics, and a psychological wellbeing platform. In addition, it offers customer loyalty programs. The company was founded in 1978 and is headquartered in Midrand, South Africa.

dischemgroup.com

--

Full Time Employees

February 28

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is All Share Index (^J203.JO) .

YTD Return

DCP.JO
30.23%
All Share Index (^J203.JO)
7.09%

1-Year Return

DCP.JO
25.99%
All Share Index (^J203.JO)
1.87%

3-Year Return

DCP.JO
2.43%
All Share Index (^J203.JO)
54.03%

5-Year Return

DCP.JO
23.51%
All Share Index (^J203.JO)
59.52%

Analyst Insights

View More

Analyst Price Targets

2,500.00
3,607.14 Average
2,442.00 Current
4,310.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.29%

  • Return on Assets (ttm)

    5.79%

  • Return on Equity (ttm)

    18.96%

  • Revenue (ttm)

    42.83B

  • Net Income Avi to Common (ttm)

    978.89M

  • Diluted EPS (ttm)

    1.04

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    499.76M

  • Total Debt/Equity (mrq)

    116.57%

  • Levered Free Cash Flow (ttm)

    1.14B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: